Rabb, Hamid - Johns Hopkins University

个人简介

Dr. Rabb attended medical school at McGill University in Montreal and graduated as University Scholar. After internship and residency in Internal Medicine at the UCLA School of Medicine, Harbor-UCLA Medical Center, he completed a clinical nephrology fellowship at the Massachusetts General Hospital and Harvard Medical School. This was followed in the same institutions by basic research training in leukocyte biology/immunology. Dr. Rabb is currently Professor and Vice Chairman (Research) in the Department of Medicine, and Medical Director of the Johns Hopkins Kidney Transplant Program. He is a member of the American Society of Clinical Investigation, American Association of Professors, a permanent member on NIH study section, and past Chair of Scientific Studies for the American Society of Transplantation. MD, McGill University Faculty of Medicine (1985)

研究领域

Biomarker discovery; Organ cross talk; Lymphocytes; Kidney ischemic injury

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Rabb H, Sharma CP, Michishita M, Brown D, Arnaout MA. Regulation of complement receptor type 3 (CD11b/CD18): function and internalization by the cytoplasmic tail of its ß-subunit (CD18). J Immunology 150:4019-4030, 1993 Rabb H, Mendiola CC, Dietz J, Saba SR, Issekutz TB, Abanilla F, Bonventre J, Ramirez G. Role of CD11a & CD11b in ischemic acute renal failure in rats. Am J Physiol Renal 267:F1052-1058, 1994 Rabb H, Martin JG. An emerging paradigm shift on the role of leukocyte adhesion molecules in inflammation. J Clin Invest 100:2937-8,1999 Kramer A, Postler G, Salhab K, Mendez C, Carey L, Rabb H. Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int 55:2362-7, 1999 Rabb H, Daniels F, O'Donnel M, Haq M, Saba S, Keane W, Tang W. Pathophysiologic role of T cells in renal ischemia reperfusion injury in mice. Am J Physiol Renal 279:F525-531, 2000 Nemoto T, Yokota N, Keane W, Rabb H. Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. Kidney Int 59:246-251, 2001 Burne M, Daniels F, Elgandour A, Muyeddi S, Colvin R, O'Donnell M, Rabb H. Identification of the CD4+ T cell as a major modulator of renal ischemia reperfusion injury. J Clin Invest 108:1283-90, 2001 Burne-Taney M, Ascon D, Yokota N, Racusen L, Baldwin W, Rabb H. B cell deficiency confers protection from renal ischemia reperfusion injury. J Immunol 171:3210-5, 2003 Craem J, Brady H, Rabb H. Cell-matrix and cell-cell interactions in the kidney. Ed. Brenner BM: Brenner & Rector's The Kidney, Saunders. 2004 Rabb H. Paracrine and differentiation mechanism underlying stem cell therapy for the damaged kidney. Am J Physiol Renal 289:F29-30, 2003